- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT01129076
Perceptions of Thalassemia Major in Singapore: An Exploratory Study of Stigma
14 dicembre 2019 aggiornato da: National Human Genome Research Institute (NHGRI)
Background:
- Thalassemia major (TM) is a chronic disorder that affects a person s ability to produce hemoglobin, resulting in anemia. Hemoglobin is a component of red blood cells that carries oxygen and nutrients to cells in the body. As a result, individuals require life-long blood transfusions and extensive medical management. Studies have shown that because of its demanding nature, TM might negatively affect an individual s quality of life, sense of self, and social integration, but little is known about affected individuals overall experiences with and perceptions of TM.
- TM is caused by a genetic change in the thalassemia gene. The disease is passed to children by parents who carry one copy of the altered thalassemia gene. The parents are called carriers of the condition and have a 25 percent chance of having a child with TM. It is possible to screen for carriers of TM and use this information for pregnancy planning and management.
- TM is common among people from South and South East Asia and is an important public health concern in Singapore. More research is needed to explore the lives of people with TM, and the societal perceptions that exist in Singapore about TM.
Objectives:
- To describe the familial, social, and professional experiences of individuals with TM.
- To investigate the social messages being given out about TM in Singapore and the sources of those messages.
- To explore the impact of these experiences, perceptions, and social messages on individuals who have TM.
- To explore how the experiences and perceptions of individuals who have TM affect their life, sense of self, social integration, and compliance with medical treatment.
Eligibility:
- Residents of Singapore who are 14 years of age or older, can speak English, and currently have TM.
- Parents of individuals with TM who are 14 years of age or older. Parents must be 21 years of age or older, be able to speak English, and have had caregiving responsibilities for their child at some point.
Design:
- All participants will have a one-time semi-structured interview, followed by a questionnaire to obtain demographic information.
- Interviews will be conducted in Singapore and are expected to last for 30 to 90 minutes.
- Individuals with TM will be asked about their own perceptions of TM; familial, social, and professional experiences involving TM; and their perceptions of others views and of social messages related to TM.
- Parents of individuals with TM will be asked about their experiences in caring for a child with TM, talking to their child about TM, telling people about their child s TM, and interacting with health care providers.
Panoramica dello studio
Stato
Completato
Condizioni
Descrizione dettagliata
Thalassemia major (TM) is a chronic, inherited hematological disorder that can require life-long medical care.
As a result of the chronic and demanding nature of the condition, studies have shown that TM might negatively affect an individual s quality of life, sense of self, social integration, and compliance with medical treatment.
Yet, little is known about affected individuals overall experiences with and perceptions of TM.
In this study, the concept of stigma will be used to explore and understand these experiences and perceptions in the population of individuals with TM in Singapore.
This study will involve qualitative interviews with TM patients and parents of TM patients.
Interviews will focus on individuals family, social and professional experiences with TM; the social messages that exist in Singapore about TM and their sources; individuals perceptions of how others view TM; individuals own perceptions of TM; and the impact of these various experiences, messages and perceptions on the individual with TM.
Interviews will be conducted with approximately 20-30 individuals with TM, and 10-20 parents of individuals with TM.
Interviews will be transcribed and subjected to thematic analysis to identify common themes.
The results of this study will further our understanding of the psychosocial burden of TM and the potential role of stigma in this population, which may ultimately inform the care for individuals with TM.
The study s setting will also provide insights into the impact of the Singaporean sociocultural context on the psychosocial elements of living with a genetic condition, which might eventually help to inform the development of appropriate psychosocial support services and genetic counseling services in the region.
Tipo di studio
Osservativo
Iscrizione (Effettivo)
30
Contatti e Sedi
Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.
Luoghi di studio
-
-
-
Singapore, Singapore
- KK Women's & Children's Hospital
-
Singapore, Singapore, 169608
- Singapore General Hospital Outram Rd.
-
-
Criteri di partecipazione
I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.
Criteri di ammissibilità
Età idonea allo studio
14 anni e precedenti (Bambino, Adulto, Adulto più anziano)
Accetta volontari sani
No
Sessi ammissibili allo studio
Tutto
Descrizione
- INCLUSION CRITERIA:
- Individuals who currently have TM and receive at least 8 blood transfusions in a year
- Residents of Singapore
- Must speak English
- Parents of individuals with TM will be eligible for participation if they are age 21 years or older
- Parents must be residents of Singapore
- Parents must speak English
- For a parent to participate in the study, it will not be required that his or her child also participate in the study or vice versa.
EXCLUSION CRITERIA:
- Children under age 14 years
- Non-English speaking individuals
Piano di studio
Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.
Come è strutturato lo studio?
Dettagli di progettazione
Collaboratori e investigatori
Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.
Pubblicazioni e link utili
La persona responsabile dell'inserimento delle informazioni sullo studio fornisce volontariamente queste pubblicazioni. Questi possono riguardare qualsiasi cosa relativa allo studio.
Pubblicazioni generali
- Major B, O'Brien LT. The social psychology of stigma. Annu Rev Psychol. 2005;56:393-421. doi: 10.1146/annurev.psych.56.091103.070137.
- Ismail A, Campbell MJ, Ibrahim HM, Jones GL. Health Related Quality of Life in Malaysian children with thalassaemia. Health Qual Life Outcomes. 2006 Jul 2;4:39. doi: 10.1186/1477-7525-4-39.
- Hoedemaekers R, ten Have H. Geneticization: the Cyprus paradigm. J Med Philos. 1998 Jun;23(3):274-87. doi: 10.1076/jmep.23.3.274.2585.
Studiare le date dei record
Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.
Studia le date principali
Inizio studio
23 aprile 2010
Completamento dello studio
7 gennaio 2016
Date di iscrizione allo studio
Primo inviato
21 maggio 2010
Primo inviato che soddisfa i criteri di controllo qualità
21 maggio 2010
Primo Inserito (Stima)
24 maggio 2010
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
17 dicembre 2019
Ultimo aggiornamento inviato che soddisfa i criteri QC
14 dicembre 2019
Ultimo verificato
7 gennaio 2016
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- 999910104
- 10-HG-N104
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .
Prove cliniche su Talassemia Maggiore
-
National Institute of Allergy and Infectious Diseases...CompletatoVariola Major (vaiolo)Stati Uniti
-
Assiut UniversityNon ancora reclutamentoTalassemia Majors (Beta-talassemia Major)
-
Sohag UniversityNon ancora reclutamentoTalassemia Majors (Beta-talassemia Major)
-
China Medical University HospitalCompletato
-
San Rocco TherapeuticsAttivo, non reclutanteDiagnosi confermata di ß-talassemia MajorItalia
-
Tanta UniversitySconosciutoNigella sativa con beta talassemia majorEgitto
-
Tanta UniversitySconosciutoAL-Hijama nella Thalassmia MajorEgitto
-
bluebird bioCompletato
-
Guangzhou Women and Children's Medical CenterReclutamentoTalassemia Majors (Beta-talassemia Major) | Donatori aploidenticiCina
-
Ataturk UniversityNon ancora reclutamentoBeta talassemia maggiore | Talassemia Majors (Beta-talassemia Major)Tacchino